Davis Polk advised The Orogen Group on its $108 million strategic equity investment in newly issued convertible preferred stock of Virtusa Corporation. The Orogen Group is…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
